Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW406381 in Adults With Osteoarthritis of the Knee
NCT00120900Phase 3Completed
- Sponsor
- GSK
- Start
- May 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of GW406381 in osteoarthritis (OA) (7 arms), sponsored by GSK. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index Pain Subscore at 12 weeks, Western Ontario and McMaster Universities Osteoarthritis Index Physical Function Subscore at 12 weeks and 1 more. Started May 2005; status: completed.
02
Drugs
GW406381
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00120900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120900.